Skip to main content
SpringerLink
Log in

Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

CYP1A1, CYP2E1, GSTM1 and GSTT1 polymorphisms were evaluated in north Indian lung cancer patients and controls. The estimated relative risk for lung cancer associated with the CYP1A1*2C allele was 2.68. Apart from the CYP1A1*2C genotype, there was no attributable risk in relation to other genotypes when analyzed singly. However, in the presence of a single copy of the variant CYP1A1 (CYP1A1*1/2A) and null GSTT1 genes, there was a three-fold increased risk for lung cancer; when stratified histologically the relative risk increased to 3.7 in case of SQCC. Similarly individuals carrying the mutant CYP1A1*2C genotype and single copy of the variant CYP1A1 Msp1 allele, had a relative risk of 2.85 for lung cancer. In case of the GSTM1 and CYP1A1 genotypes, null GSTM1 and variant Msp1 alleles had two-fold elevated risk for SQCC. On the other hand CYP1A1*2C and null GSTM1 genotype had a 3.5-fold elevated risk for SCLC. Stratified analysis indicated a multiplicative interaction between tobacco smoking and variant CYP1A1 genotypes on the risk for SQCC and SCLC. The heavy smokers (BI < 400) with CYP1A1*2C genotype were at a very high risk to develop SCLC with an OR of 29.30 (95% CI = 2.42–355, p= 0.008). Taken together, these findings, the first to be analyzed in north Indian population, suggest that combined GSTT1, GSTM1 and CYP1A1 polymorphisms could be susceptible to lung cancer induced by bidi (an Indian cigarette) smoking (Mol Cell Biochem 266: 1–9, 2004)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fhelinger BJ, Kimmel M, Polyak T, Melamed MR: Screening for lung cancer, the Mayo lung project revisited. Cancer (Phila) 72: 1572–1580, 1993

    Google Scholar 

  2. Strauss GM: Measuring effectiveness of lung cancer screening: From consensus to controversy and back. Chest 112(suppl 4): 216S–228S, 1997

    Google Scholar 

  3. Doll R: Uncovering the risk of smoking: Historical perspective. Stat Meth Med Res 7: 87–117, 1998

    Google Scholar 

  4. Marchand Le, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, Lau AF: Association of CYP1A1, GSTM1, and CYP2E1 poly-morphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58: 4858–4863, 1998

    Google Scholar 

  5. Garcia-Closas M, Kelsey KT, Wiencke J, Xu X, Wain JC, Christiani DC: A case control study of cytochrome P4501A1, glutathione-S-transferases M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States). Cancer Causes Control 8: 544–553, 1997

    Google Scholar 

  6. Ketterer B, Harris JM, Talaska GD, Meyer J, Pemble SE, Taylor JB, Lang NP, Kadulbar FF: The human glutathione-S-transferase super gene family, its polymorphism and its effect on susceptibility to lung cancer. Environ Health Perspect 98: 86–94, 1992

    Google Scholar 

  7. Nerbert DW: Role of genetics and drug metabolism in human cancer risks. Mutat Res 247: 267–281, 1991

    Google Scholar 

  8. Kiyohara C, Shirakawa T, Hopkin JM: Genetic polymorphism of enzymes involved in xenobiotics metabolism and the risk of lung cancer. Environ Health Prevent Med 7: 47–59, 2002

    Google Scholar 

  9. Kiyohara C, Nakanishi Y, Inutsuka S, Takayama K, Hara N, Tanaka K, Kono S, Hirohata T: The relationship between CYP1A1 and aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. Pharmacogenetics 8: 315–323, 1998

    Google Scholar 

  10. Song N, Tan W, Xing D, Lin D: CYP1A1 polymorphism and risk to lung cancer in relation to tobacco smoking: A case-control study in China. Carcinogenesis 22: 11–16, 2001

    Google Scholar 

  11. Petersen DD, McKinney CE, Iyeka K, Smith HH, Bale AE, McBride OW, Nerbert DW: Human CYP1A1 gene: Co-segregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 48: 720–725, 1991

    Google Scholar 

  12. Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, Cosma G, Caporaso N: Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4: 242–246, 1994

    Google Scholar 

  13. Crofts F, Taioli E, Trachmann J, Cosma GN, Currie D, Toniolo P, Garte SJ: Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15: 2961–2963, 1993

    Google Scholar 

  14. Cosma GN, Crofts F, Currie D, Wirgin I, Toniolo P, Garte SJ: Racial differences in restriction fragment length polymorphism and mRNA inducibility in human CYP1A1 gene. Cancer Epidemiol Biomarker Prev 2: 53–57, 1993

    Google Scholar 

  15. Garte SJ: The role of ethnicity in cancer susceptibility gene polymorphisms: The example of CYP1A1. Carcinogenesis 19: 1329–1332, 1998

    Google Scholar 

  16. Hayashi S, Watanabe J, Kawajiri K: High susceptibility to lung cancer analyzed in terms of combined genotypes of CYP1A1 and Mu class glutathione-S-transferase genes. Jpn J Cancer Res 83: 866–870, 1992

    Google Scholar 

  17. Nakachi K, Imai K, Hayashi S, Kawajiri K: Polymorphisms of the CYP1A1 and glutathione-S-transferase genes associate with susceptibility to lung cancer in relation to cigarette dose in Japanese population. Cancer Res 53: 2994–2998, 1993

    Google Scholar 

  18. Sugimura H, Wakai K, Genka K, Nagura K, Igarashi H, Nagayama H, Ohkawa A, Baba S, Morris BJ, Tsugane S, Ohno Y, Gao C, Li Z, Takezaki T, Tajima K, Iwamasa T: Association of Ile-462-Val (exon7) polymorphism of cytochrome P4501a1 with lung cancer in the Asian population: Further evidence from a case-control study in Okinawa. Cancer Epidemiol Biomarker Prev 7: 413–417, 1998

    Google Scholar 

  19. Lin P, Wang SL, Wang JH, Chen KW, Lee HS, Tsai KJ, Chen CY, Lee H: Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma. Br J Cancer 82: 852–857, 2000

    Google Scholar 

  20. Hirvonen A, Pursianen KH, Karjalainen A, Antilla S, Vanio H: Point mutational Msp1 and CYP1A1*1/*2C polymorphism closely linked in the CYP1A1 gene; lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarker Prev 1: 485–489, 1992

    Google Scholar 

  21. Shields PG, Caporaso NE, Falk RI, Sugimura H, Trivers GHE, Trump F, Hoover RN, Weston A, Harris CC: Lung cancer, race and a CYP1A1 genetic polymorphism. Cancer Epidemiol Biomarker Prev 2: 581–485, 1993

    Google Scholar 

  22. Bouchardy C, Wikman H, Benhamou S, Hirvonen P, Dayer A, Husgafvel-Pursianen K: YP1A1 genetic polymorphism, tobacco smok-ing and lung cancer risk in a French Caucasian population. Biomarker 2: 131–134, 1997

    Google Scholar 

  23. Xu X, Kelsey KT, Wiencke JK, Wain JC, Christiani DC: Cytochrome P450 CYP1A1 Msp1 polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarker Prev 5: 687–692, 1996

    Google Scholar 

  24. Hamada GS, Sugimura H, Suzuki I, Kiyokawa E, Nagura K, Iwase T, Tanaka M, Takahashi T, Watanabe S, Kino I, Tsugane S: The hemebinding region polymorphism of cytochrome P4501A1 (CYP1A1), rather then the Rsa1 polymorphism of 2E1 (CYP2E1) is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol Biomarker Prev 4: 63–67, 1995

    Google Scholar 

  25. Sugimura H, Hamada GS, Suzuki I, Iwase T, Kiyokawa E, Kino I, Tsugane S: CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro. Pharmacogenetics 5: 145–148, 1995

    Google Scholar 

  26. Quinones L, Lucas D, Godoy J, Caceres D, Berthou F, Varela N, Lee KC, Acevedo L, Martinez AM, Aguilera L: CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 174: 35–44, 2001

    Google Scholar 

  27. Umetasu F, Kikuchi H, Motomiya M, Abe T, Sagami I, Ohmachi T, Wakui A, Kanamaru R, Watanabe M: Association between RFLP of human cytochrome P402e1 gene and susceptibility to lung cancer. Jpn J Cancer Res 82: 254–256, 1991

    Google Scholar 

  28. Koop DR: Oxidative and reductive metabolism by cytochromeP4502E1. FASEB J 6: 724–730, 1992

    Google Scholar 

  29. Yamazaki H, Inui Y, Yun C, Guengerich FP, Shimada T: Cytochrome P402E1 and 2A6 as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco related nitosoamines in human liver microsomes. Carcinogenesis 13: 1789–1794, 1992

    Google Scholar 

  30. Kato S, Shields PG, Caporaso NE, Sugimura H, Trivers GE, Tucker A, Trump BF, Weston A, Harris CC: Analysis of cytochrome P4502e1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol Biomarker Prev 3: 515–518, 1994

    Google Scholar 

  31. Hayashi I, Watanabe J, Kawajiri K: Genetic polymorphisms in the 5′ flanking region change transcriptional regulation of the human cytochrome P4502e1 gene. J Biochem 110: 559–565, 1991

    Google Scholar 

  32. Hirvonen A, Husgafvel-Pursianen K, Anittila S, Karjalainen A, Vanio H: The human CYP2E1 gene and lung cancer: Dra1 and Rsa1 RFLP in a Finnish study population. Carcinogenesis 14: 85–88, 1993

    Google Scholar 

  33. Person I, Johansson I, Bergling H, Dahl M, Seidegard I, Rylander K, Rannug A, Hogberg J, Sundberg MI: Genetic polymorphism of the cytochrome P4502e1 in a Swedish population relationship to incidence to lung cancer. FEBS Lett 319: 207–211, 1993

    Google Scholar 

  34. Hayes JD, Pultford DJ: The glutathione-S-transferase super gene family: Regulation of GST and the contribution of the isoenzymes to cancer chemo protection and drug resistance. Crit Rev Biochem Mol Biol 30: 445–600, 1995

    Google Scholar 

  35. Ophius MB, Lieshout MM, Reolofs MJ, Peter HM, Manni JJ: Glutathione-S-transferase M1 and T1 and cytochrome P4501a1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer (Phila) 82: 936–943, 1998

    Google Scholar 

  36. Brockmoller J, Kerb K, Drakoulis N, Roots I: Genotype and phenotype of glutathione-S-transferase of class mu isoenzymes and psi of lung cancer patients and controls. Cancer Res 53: 1004–1011, 1993

    Google Scholar 

  37. Hirvonen A, Husgafvel-Pursianen K, Antilla S, Vanio H: The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14: 1479–1481, 1993

    Google Scholar 

  38. Figueras J, Gene M, Gomez J, Galan MC, Fuentes MJ, Ramon M, Rodamilans M, Huguet E, Corbella J: Glutathione-S-transferase M1 (GSTM1) and (GSTT1)T1polymorphism and lung cancer risk among north western Mediterranean's. Carcinogenesis 18: 1529–1533, 1997

    Google Scholar 

  39. Malats N, Nyberg F, Ahrens W, Lang M, Benhamou S, Mukeria A, Boffetta P: Glutathione-S-transferase lung cancer risk in non smokers and GSTM1 and GSTT1 genetic polymorphism. Cancer Epidemiol Biomarker Prev 9: 827–833, 2000

    Google Scholar 

  40. Brockmoller J, Cascorbi I, Kerb K, Roots I: Combined analysis of inherited polymorphism in arylamine N-acetyl transferase 2, glutathione-S-transferase M1 and T1, microsomal epoxides hydroxylase and cytochrome P4501A1 enzymes as modulators of bladder cancer risk. Cancer Res 56: 3915–3925, 1996

    Google Scholar 

  41. Kiyohara C, Yamamura K, Nakanishi Y, Takayama K, Hara N: Polymorphism in GSTM1, GSTT1 and GSTP1 and susceptibility to lung cancer in a Japanese population. Asian Pacific J Cancer 1: 293–298, 2000

    Google Scholar 

  42. Tan LQ, He X, Costa DJ, Tian LN, Rothman G, Hua JL, Mumford L: Lung cancer risk innonsmokers and GSTM1 and GSTT1 genetic polymorphism. Cancer Epidemiol Biomarker Prev 9: 827–833, 2000

    Google Scholar 

  43. Seidegard J, Pero RW, Miller DG: Aglutathione-S-transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 7: 751–753, 1986

    Google Scholar 

  44. Field JK, Liloglou T, Xinarianos S, Prime GP, Fielding W, Walshaw JM, Turnbull L: Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung Cancer. Cancer Res 59: 2690–2695, 1999

    Google Scholar 

  45. Sivaraman L, Leatham MP, Yee JR, Wilkens L, Lau AF, Marchand L: CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 54: 3692–3695, 1994

    Google Scholar 

  46. Arand M, Muhlbauer RJ, Hengstler E, Jager J, Fuchs L, Winkler F: A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione-S-transferase GSTM1 and GSTT1 polymorphism. Anal Biochem 236: 184–186, 1996

    Google Scholar 

  47. Okada T, Kawashima K, Fukishi S, Minakuchi T, Nishimura S: Association between a cytochrome P450 CYP1A1 genotype and incidence of lung cancer. Pharmacogenetics 4: 333–340, 1994

    Google Scholar 

  48. Hong YS, Chang JH, Kwon OJ, Ham YA, Choi JJ: Polymorphism of the CYP1A1 and glutathione-S-transferase genes in Korean lung cancer patients. Exp Mol Med 30: 192–198, 1998

    Google Scholar 

  49. Sreelekha K, Ramadas M, Pandey G, Thomas KR, Pillai MR: Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 37: 593–598, 2001

    Google Scholar 

  50. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J: Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of cytochrome P4501A1 gene. FEBS Lett 263: 131–133, 1990

    Google Scholar 

  51. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K: Genetic susceptibility to squamous cell carcinoma of the lung in relation to tobacco smoking dose. Cancer Res 51: 5177–5180, 1991

    Google Scholar 

  52. Nakachi K, Hayashi S, Kawajiri FK, Imai K: Association of cigarette smoking and CYP1A1 polymorphism with adenocarcinoma of the lung by grades of differentiation. Carcinogenesis 16: 2209–2213, 1995

    Google Scholar 

  53. Tefre T, Ryberg D, Haugen A, Nerbet DW, Skaug V, Brogger A: Human CYP1A1 gene: Lack of association between the Msp1 restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1: 20–25, 1991

    Google Scholar 

  54. Drakoulis N, Cascorbi I, Brockmoller J, Gross CR, Roots I: Polymorphism in the human CYP1A1 gene as susceptibility factors for lung cancer: Exon 7 mutation (4889 A to G) and a T to C mutation in the 3′ flanking region. Clin Invest 72: 240–248, 1994

    Google Scholar 

  55. Cascorbi I, Brockmoller J, Roots I: A C4887A polymorphism in exon7 of human CYP1A1: Population frequency, mutation linkages and impact on lung cancer susceptibility. Cancer Res 56: 4965–4969, 1996

    Google Scholar 

  56. Zhang ZY, Fasco MJ, Huang L, Guengerich P, Kaminsky LS: Characterization of purified human recombinant cytochrome P4501A1-Ile462 and Val462: Assessment of a role for the rare allele in carcinogenesis. Cancer Res 56: 3926–3933, 1996

    Google Scholar 

  57. Kihara M, Kihara M, Noda K: Risk of smoking for squamous and small cell carcinoma of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphism in Japanese population. Carcinogenesis 16: 2331–2336, 1995

    Google Scholar 

  58. Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, Schwartz BS, Lee BK, Spitz MR, Wang M, Xu X: Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione-S-transferase theta. Carcinogenesis 16: 1243–1245, 1995

    Google Scholar 

  59. Journekova N, Reinikanen M, Bouchardy C, Dayer P, Ben Hausou S, Hirvonen A: Laeynx risk in relation to gluthathion-s-transferase M1 and T1 genotypes and tobacco smoking. Cancer Epidemiol. Biomarkers 7: 19–23, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biotechnology, Punjab University, Chandigarh, India.

    R.C. Sobti, S. Sharma & A. Joshi

  2. Department of Pulmonary Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India

    S.K. Jindal

  3. Department of Chest and Infectious Diseases, Government Medical College, Chandigarh, India

    A. Janmeja

Authors
  1. R.C. Sobti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Joshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S.K. Jindal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Janmeja
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sobti, R., Sharma, S., Joshi, A. et al. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem 266, 1–9 (2004). https://doi.org/10.1023/B:MCBI.0000049127.33458.87

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MCBI.0000049127.33458.87

Search

Navigation